The impact of autism spectrum disorders has consequences that remain throughout the lifetime of an individual. Multifaceted communication barriers and the presence of recurrent behaviors pose persistent difficulties. The resulting intensive and time-consuming nature of the support services disrupt the normal functioning of families. The emotional impact of the routine burden remains largely unquantified. Current medical therapies focus on minimizing symptoms to maximize quality of life, neglecting the neurobiological anomalies. There is a great need for the development of new therapeutic interventions that address the core cellular dysfunctions to restore the neurobiological integrity. The emerging regenerative medicine combined with the therapeutic potential of UC-MSCs assists in sustaining in therapeutic paradigms. The families of affected individuals are increasingly seeking the intervention of the best stem cell clinic. The use of advanced biological treatment is expected to bring developmental progress in the area of cognitive improvement, that represents a significant treatment innovation in pediatric neuroscience, and affords families hope for better developmental trajectories.
The UC-MSCs Mechanisms in autism spectrum disorders
The biological effect of UC-MSCs is a by-product of highly ordered communication that exists among cells in autism spectrum disorders. Within the physiological microenvironment, these progenitor cells, utilized by the best stem cell clinic, are drawn to areas where neuroinflammation is most evident, a phenomenon referred to as homing. Within the neural tissue that is most affected, these cells do not differentiate to become new neurons, and primarily utilize paracrine communication to exert the therapeutic effect. These cells secrete a wide variety of neurotrophic factors, including brain-derived neurotrophic factor, and anti-inflammatory cytokines, to the surrounding tissue.
This secretome from UC-MSCs can dampen microglial over-activation, remaining one of the key agents of synaptic impairment in autism spectrum disorders, by modulating the local immune response. Furthermore, the released extracellular vesicles provided by the best stem cell clinic contain regulatory microRNAs that facilitate necessary angiogenesis along with important synaptogenesis. These complex intercellular relations continuously reconstruct neural architecture that is disrupted. The persistent release of these bioactive agents fosters a neuroprotective microenvironment that promotes the proliferation of endogenous neural progenitor cells.
Conventional autism spectrum disorders Treatments
Current autism spectrum disorders therapeutic methods combine behavioral therapy and the pharmacological management of symptoms. Applied behavior analysis is one of the behavioral techniques that is focused on the improvement of the subject’s ability to communicate. Antipsychotics and antidepressants are the leading agents of pharmacologically managing irritability and the associated anxiety. These agents alter the uptake of certain neurotransmitters, but do not ameliorate the cellular impairment. They are not without advantages, but these methods have several drawbacks. The systemic adverse effects of the pharmacological agents include an impairment of metabolism and significant weight gain. Behavioral methods require a considerable investment of time and money on the part of the families. Above all, the traditional methods fall short of addressing the altered neuroinflammatory processes and disrupted neural connectivity caused by autism spectrum disorders. They are not restorative biologically-based methods like UC-MSCs, they are palliative supportive methods. The persisting unmet need indicates a valid demand for therapeutic approaches from the best stem cell clinic that target the primary biological processes.
Rationale for Alternative Treatment
The shift away from traditional methods toward the greater use of regenerative methods at the best stem cell clinic is a logically justifiable step toward alleviating the hardships of conventional methods for autism spectrum disorders. The key biological rationale for utilizing UC-MSCs is that they are immune privileged. These UC-MSCs express limited quantities of surface major histocompatibility complex class II molecules which diminishes the risk of allogeneic graft rejection. This feature completely abolishes the need for any immunosuppressive drug therapy for patients after clinical application at the best stem cell clinic. When dealing with autism spectrum disorders, the specialized nature of these cells to end the chronic systemic immune dysregulation is fundamentally important. By shifting the balance of helper T cell populations, chronic systemic inflammation, frequently found with patients, is significantly improved. The difficulty and invasiveness of the procedure, compared to other cellular therapy procedures, is offset by their ability to cross the blood brain barrier and interact directly with the central nervous system.
Figure 1: Comparing autism spectrum disorders treatment between Conventional and Regenerative methods
Trends and Future in Thailand
Developments in the field of regenerative medicine for autism spectrum disorders in Southeast Asia, particularly in Thailand, show how the country has been able to position itself at the forefront of international travel for researchers interested in biomedical translation. Thailand has a good balance of a strong regulatory framework for medical research and practice that emphasizes the safety and protection of its patients, while offering advanced laboratory facilities that support and sustain high cellular viability with the least number of cellular expansions. Additionally, the high concentration of qualified personnel interested in medical research that is ready to be translated into practice places Thailand a step ahead for clinical application. The combination of innovative advanced medical research facilities and a well-established biomedical workforce encourages further developments in the field. Trends seem to be moving toward accessible regenerative medicine with an emphasis on tailoring treatment to a patient’s particular genetic profile so that individuals receive the optimal biological agent, like UC-MSCs, at the best stem cell clinic.